CYDEPS Dose Escalation Pain Study

CYDEPS – Dose escalation pain study  The CYDEPS clinical trial is investigating the use of a medical cannabis product as a potential treatment for chronic back and/or neck pain. The study is a single arm, open label clinical study which means everyone who participates will receive the experimental medication (there is no placebo). The clinical […]

Cybis 10:25 Released

Cymra’s flagship clinical product Cybis is now released an on the market through our distributor. Its Australian grown cannabis under Good Agricultural Practice and Australian manufactured under Good Manufacturing Practice. Full spectrum profile with Linalool the dominant terpene, alongside bisabolol and betacaryophellene providing potential benefits of the entourage effects. Linalool has shown to reduce anxiety […]